Alain Morvan - Coloplast VP Europe
| COLO-B Stock | DKK 889.40 2.40 0.27% |
Insider
Alain Morvan is VP Europe of Coloplast AS
| Phone | 45 49 11 11 11 |
| Web | https://www.coloplast.com |
Coloplast Management Efficiency
The company has return on total asset (ROA) of 0.1714 % which means that it generated a profit of $0.1714 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.7507 %, meaning that it generated $0.7507 on every $100 dollars invested by stockholders. Coloplast's management efficiency ratios could be used to measure how well Coloplast manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Aurangzeb Khan | GN Store Nord | N/A | |
| Jannik Larsen | Investeringsselskabet Luxor AS | 54 | |
| Cristina Hefting | HusCompagniet AS | N/A | |
| Helle Futtrup | Fast Ejendom | N/A | |
| Thomas Schmidt | Ambu AS | 52 | |
| Jorgen Moeller | DSV Panalpina AS | 70 | |
| Anne Veyhe | GN Store Nord | N/A | |
| Rolf Srensen | Bavarian Nordic | N/A | |
| Ejvindgensen | cBrain AS | N/A | |
| Clint Redman | PF Atlantic Petroleum | N/A | |
| MarieLouise Aamund | DSV Panalpina AS | 51 | |
| Tony Summerlin | cBrain AS | N/A | |
| Henrik MSc | Bavarian Nordic | 58 | |
| Anu Kerns | Bavarian Nordic | 51 | |
| Dorte Keller | Fast Ejendom | N/A | |
| Lars AndersenLange | GN Store Nord | N/A | |
| Thomas Henriksen | Ambu AS | 50 | |
| JeanChristophe May | Bavarian Nordic | 56 | |
| Michael Ebbe | DSV Panalpina AS | 53 | |
| Laurence Moerlooze | Bavarian Nordic | 59 | |
| Peter Gormsen | GN Store Nord | 49 | |
Management Performance
| Return On Equity | 0.75 | |||
| Return On Asset | 0.17 |
Coloplast AS Leadership Team
Elected by the shareholders, the Coloplast's board of directors comprises two types of representatives: Coloplast inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Coloplast. The board's role is to monitor Coloplast's management team and ensure that shareholders' interests are well served. Coloplast's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Coloplast's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ellen Bjurgert, VP Relations | ||
| Allan Rasmussen, Ex Operations | ||
| Alain Morvan, VP Europe | ||
| Nicolai Andersen, Ex Innovation | ||
| Thomas Barfod, Controller Director | ||
| Anders LonningSkovgaard, Ex CFO | ||
| Kristian Villumsen, Pres CEO | ||
| Paul Marcun, Ex Growth | ||
| Dennis Kaysen, Director Communications | ||
| Dorthe Ronnau, VP Culture |
Coloplast Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Coloplast a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.75 | |||
| Return On Asset | 0.17 | |||
| Profit Margin | 0.20 % | |||
| Operating Margin | 0.30 % | |||
| Current Valuation | 203.46 B | |||
| Shares Outstanding | 194.31 M | |||
| Shares Owned By Insiders | 35.00 % | |||
| Shares Owned By Institutions | 25.53 % | |||
| Price To Earning | 42.10 X | |||
| Price To Book | 22.36 X |
Pair Trading with Coloplast
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Coloplast position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coloplast will appreciate offsetting losses from the drop in the long position's value.Moving together with Coloplast Stock
The ability to find closely correlated positions to Coloplast could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Coloplast when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Coloplast - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Coloplast AS to buy it.
The correlation of Coloplast is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Coloplast moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Coloplast AS moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Coloplast can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Coloplast Stock
Coloplast financial ratios help investors to determine whether Coloplast Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Coloplast with respect to the benefits of owning Coloplast security.